MYC and thymus lymphoma: Because thymic lymphomas were the second most frequently occurring tumor type in both Myc-WT;p53KO and Myc+/−;p53KO mice, we checked whether Myc expression in these tumors was also dosage compensated, and if Myc levels were also supraphysiologic in these tumors.